SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (7595)5/5/1999 9:01:00 AM
From: James  Read Replies (1) | Respond to of 9523
 
Viagra does work in some women, study finds

infobeat.com

Cheers,

James

& hang in there all PFE longs. View this weakness as a great opportunity!



To: BigKNY3 who wrote (7595)5/5/1999 2:32:00 PM
From: BigKNY3  Read Replies (3) | Respond to of 9523
 
One reason for yesterday's weakness.

BigKNY3

Pfizer Inc. Maintained 'Underperform' at DLJ

Bloomberg News
May 4, 1999, 6:39 a.m. PT
Princeton, New Jersey, May 4 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was maintained ''underperform'' by analyst Kent Blair at Donaldson Lufkin & Jenrette Securities Corp. The 12-month target price is $100.00 per share.